A forehead support apparatus for resting a standing users forehead against a wall above a bathroom commode or urinal or beneath a showerhead.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7354771 | Method of determining absolute configuration of chiral compound The absolute configuration of a chiral compound is determined by (i) coordinating the chiral compound to a metalloporphyrin having a carbon chain-crosslinked porphyrin dimer structure in which one of the two porphyrin rings has at least one ethyl or substituent bulk... | 04/08/2008 |
| 7342009 | Cyclic sulfonamides for inhibition of gamma-secretase Compounds of formula I: inhibit the processing of APP by gamma-secretase, and hence are useful in the treatment or prevention of Alzheimer's disease. ... | 03/11/2008 |
| 7342010 | 2-thiaquinolizidines and process for the preparation thereof A process for producing 2-thiaquiolizidines which are glycosidase and glycosyltransferase inhibitors is described. The compounds are of the formula: where x is 0 to 3. ... | 03/11/2008 |
| 7030238 | C-nitroso compounds and use thereof A C-nitroso compound having a molecular weight ranging from about 225 to about 1,000 (from about 225 to about 600 for oral administration) on a monomeric basis wherein a nitroso group is attached to a tertiary carbon, which is obtained by nitrosylation of a carbon a... | 04/18/2006 |
| 6960579 | Serotonergic 5HTreceptor compounds for treating ocular and CNS disorders Compounds with 5HT7 receptor affinity (some of which are novel) useful for lowering IOP, improving blood flow to the optic nerve head and the retina, providing neuroprotection, and treating retinal diseases are disclosed. The Compounds are also useful for... | 11/01/2005 |
| 6933304 | Heteroarylalkanoic acids as integrin receptor antagonists The present invention relates to a class of compounds represented by the Formula I or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of select... | 08/23/2005 |
| 6841559 | Pyridinones to treat and prevent bacterial infections Novel pyridinones and their derivatives which are effective in treating or preventing Gram-negative bacterial infections are provided. The pyridinones are stable and easily derivatized; the methods by which these derivatizations occur is described. Two regioselectiv... | 01/11/2005 |
| 6825184 | 1,4-Disubstituted benzo-fused urea compounds Disclosed are compounds of the formulas (I) & (II) shown below which are active as anti-inflammatory agents. Also disclosed are methods of using and making such compounds. wherein G, X, A and Q are described herein. | 11/30/2004 |
| 6756370 | Piperidine alcohols The invention relates to compounds of formula (I), wherein R1, R2 and A have the meanings given in claim 1, are potent 5-HT2A antagonists and are suitable for treating psychoses, schizophrenia, depression, neurological disorders, imp... | 06/29/2004 |
| 6730681 | Triazolo-pyrimidine derivatives as ligands for gaba receptors A class of substituted or 6,7-ring fused [1, 2, 3]triazolo[1,5-α]-pyrimidine derivatives, possessing an optionally substituted cycloalkyl, phenyl or heteroaryl substituent at the 3-position and an amino moiety at the 5-position, are selective ligands for GABAA... | 05/04/2004 |
| 6727258 | Allosteric adenosine receptor modulators The present invention relates to compounds of formula (IA): the preparation thereof, pharmaceutical formulations thereof, and their use in medicine as allosteric adenosine receptor modulators for uses including protectio... | 04/27/2004 |
| 6713477 | Hydroxamic acid derivatives A hydroxamic acid derivative represented by formula (1) or a prodrug thereof, or a pharmaceutically acceptable salt thereof, which has a matrix metalo-proteinase inhibitor. ... | 03/30/2004 |
| 6649758 | Preparation of trans-thiazineindigo pigments A process for preparing symmetrical or asymmetrical trans-thiazineindigo pigments of the formula (1) ##STR1## which comprises a) condensing, in an aqueous medium, a compound of the formula (2) with a compound of the formula (3a) or (3b) or a compound ... | 11/18/2003 |
| 6531484 | Pyrrolidine modulators of CCR5 chemokine receptor activity Pyrrolidine compounds of Formula I: ##STR1## (wherein R1, R2, R3, R4, R5, R6, R7, R8a, R8b, j, k, 1, m, and n are defined herein) are described. The compoun... | 03/11/2003 |
| 6455522 | Cyclic sulfonamide derivatives as metalloproteinase inhibitors The present application describes novel lactams and derivatives thereof of formula I: ##STR1## or pharmaceutically acceptable salt forms thereof, wherein rings ring B is a 4-8 membered cyclic sulfonamide containing from 0-3 additional heteroatoms sel... | 09/24/2002 |
| 6432945 | Dipeptide derivatives This invention is directed to compounds of the formula ##STR1## and the pharmaceutically-acceptable salts thereof, where the substituents are as defined in the Specification, which are growth hormone secretogogues and which increase the level of endogenou... | 08/13/2002 |
| 6369223 | Asymmetric cycloaddition reactions The present invention relates to a process for stereoselective cycloaddition reactions which generally comprises a cycloaddition reaction between a pair of substrates, each either chiral or prochiral, that contain reactive π-systems, in the presence of a... | 04/09/2002 |
| 6340752 | Deprotection and recrystallization processes Acylmercaptoalkanoylamino lactam esters or acids are converted to the corresponding mercaptoalkanoylamino lactam ester or acid under basic conditions by including an agent which minimizes the amount of disulfides. Suitable agents are bismercaptans, phosph... | 01/22/2002 |
| 6200378 | Thiazine indigo pigments, solid solutions thereof and their preparation A compound according to the formula (I) ##STR1## wherein R1 and R2 are independently the atoms necessary to complete the formation of a substituted or unsubstituted aromatic or aliphatic carbocyclic or heterocyclic ring system and R | 03/13/2001 |
| 6194426 | 5,6,7,8 tetrahydroindolizines derivatives A novel therapeutic use of pyrrole derivatives of the folloeing formula: ##STR1## in which the variables are as defined in the specification and their salts thereof for treating conditions in which TNF is involved.... | 02/27/2001 |
| 6057314 | Low molecular weight bicyclic thrombin inhibitors This invention relates to the discovery of heterocyclic competitive inhibitors of the enzyme thrombin, their preparation, and pharmaceutical compositions thereof. As well, this invention relates to the use of such compounds and compositions in vitro as an... | 05/02/2000 |
| 6046211 | Amidino derivatives useful as nitric oxide synthase inhibitors The current invention discloses useful pharmaceutical compositions containing amidino derivative useful as nitric oxide synthase inhibitors.... | 04/04/2000 |
| 5994274 | Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides The present invention relates to new compounds of the formula (I) ##STR1## in which X represents alkyl, Y represents halogen or alkyl and Z represents halogen or alkyl, with the proviso that one of the radicals Y and Z always represents halogen and the ot... | 11/30/1999 |
| 5990145 | Vitronectin receptor antagonists, their preparation and their use The present invention relates to compounds of the formula I, A--B--D--E--F--G (I) in which A, B, D, E, F and G have the meanings given in the patent claims, to their preparation and to their use as medicaments. The compound... | 11/23/1999 |
| 5939415 | A!-annellated pyrrole derivatives and their use in pharmacology The present invention relates to heterocyclic compounds with the formula ##STR1## in which R1 to R7, B, a, and X have the meanings indicated in the specification. These compounds can be used for the treatment of diseases of the ... | 08/17/1999 |
| 5780465 | 4-substituted 5-polycyclylpyrimidine herbicides 4-Substituted 5-polycyclylpyrimidine compounds in which the 5-substituent is polycyclic and is attached to the pyrimidine moiety through an aliphatic carbon atom, such as 5-(2,2-dimethylindan-1-yl)-4-methylthiopyrimidine, were prepared and found to p... | 07/14/1998 |
| 5726126 | 1-(3-heterocyclyphenyl)-S-triazine-2,6,6-oxo or thiotrione herbicidal agents There is provided a 1-(3-heterocyclylphenyl)-s-triazine-2, 4,6-oxo or thiotrione compound having the structural formula I ##STR1## Further provided are a composition and a method comprising that compound for the control of undesirable plant species.... | 03/10/1998 |
| 5708169 | 5-amidomethyl ,ଲ-saturated and -unsaturated 3-aryl butyrolactone antibacterial agents The present invention provides for new 5-amidomethyl, ,ଲ-saturated and--unsaturated butyrolactone antibacterial agents of formula I ##STR1## characterized by 3-aryl substituents that include, for example, indolinyl and phenyl substi... | 01/13/1998 |
| 5705639 | Process to prepare herbicidal bicyclic triazoles This invention includes compounds of Formula II and IV and a process for preparing Formula I compounds by first preparing the compounds of Formula IV and then further reacting to form the compounds of Formula II and further reacting to prepare the compoun... | 01/06/1998 |
| 5654294 | Spiro lactam dual action inhibitors Compounds of the formula ##STR1## are disclosed as possessing inhibotory activity against angiotensin converting enzyme (ACE) and neutral endopeptidase (NEP) and thus being useful as cardiovascular agents. Processes for preparing these compounds ... | 08/05/1997 |
| 5646276 | Diazepine containing dual action inhibitors Compounds of the formula ##STR1## wherein X1 is ##STR2## are disclosed as possessing inhibotory activity against angiotensin converting enzyme (ACE) and neutral endopeptidase (NEP) and thus being useful as cardiovascular agents.... | 07/08/1997 |
| 5639745 | Fused-bicyclic lactams as interleukin-1ଲ converting enzyme inhibitors Disclosed are compounds, compositions and methods for inhibiting interleukin-1ଲ protease activity. The compounds, bicyclic derivatives of aldehydes and -substituted methyl ketones, have the formula (A) set out herein.... | 06/17/1997 |
| 5627278 | Process for preparing compounds containing a fused bicyclic ring A process for preparing compounds of the formula ##STR1## wherein X is O or S; n is one or two; m is zero or one; Y is CH2, O, or S provided that Y is O or S only when m is one; and A is ##STR2## is disclosed. Also disclosed are proce... | 05/06/1997 |
| 5602236 | Metal-containing steroid mimics and ligands useful in the preparation thereof Metal-containing steroid mimic complexes are provided. Compositions containing a metal ion incorporated into a steroid skeleton structure and ligands useful in the preparation of such compositions are also provided. The metal ion is preferably a radionucl... | 02/11/1997 |
| 5599815 | Antipsychotic benzoisothiazolyl piperazine derivatives Compounds represented by the formula (I) and pharmacologically acceptable salts thereof: ##STR1## These compounds have little extrapyramidal effect and thus are effective as an anti-psychotic agent having few side effects.... | 02/04/1997 |
| 5563148 | Specific 5-HT3 antagonists This invention provides bicyclic carboxylic esters and amides, their pharmaceutical formulations, and a method for their use in treating migraine, emesis, gastrointestinal disorders, schizophrenia, or anxiety in mammals.... | 10/08/1996 |
| 5552400 | Fused-bicyclic lactams as interleukin-1ଲ converting enzyme inhibitors Disclosed are compounds, compositions and methods for inhibiting interleukin-1ଲ protease activity. The compounds, bicyclic derivatives of aldehydes and -substituted methyl ketones, have the formula (A) set out herein.... | 09/03/1996 |
| 5552397 | Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase Compounds of the formula ##STR1## are disclosed as possessing inhibitory activity against angiotensin converting enzyme (ACE) and neutral endopeptidase (NEP) and thus being useful as cardiovascular agents. Processes for preparing these compounds ... | 09/03/1996 |
| 5364863 | Specific 5-HT3 antagonists This invention provides bicyclic carboxylic esters and amides, their pharmaceutical formulations, and a method for their use in treating migraine, emesis, gastrointestinal disorders, schizophrenia, or anxiety in mammals.... | 11/15/1994 |
| 5356862 | Herbicidal sulfonylureas The invention relates to herbicidal sulfonylurea compounds, agriculturally suitable compositions thereof and a method for their use as general or selective preemergent or postemergent herbicides or plant growth regulants.... | 10/18/1994 |